LOGIN  |  REGISTER
C4 Therapeutics

List of Medical Distribution Stocks

Company
Last Trade
Change
Volume
Shares Out
Market Cap
US$ 536.85
-2.41 -0.45
591,181
131.41M
US$ 70.550B
US$ 111.90
-0.64 -0.57
1.55M
243.23M
US$ 27.220B
US$ 75.52
0.37 0.49
916,408
128.51M
US$ 9.710B
US$ 72.56
-0.07 -0.10
208,314
49.65M
US$ 3.600B
US$ 27.65
-0.14 -0.50
628,535
89.59M
US$ 2.480B
US$ 27.71
-0.24 -0.86
465,991
76.60M
US$ 2.120B
US$ 1.92
-0.01 -0.52
2,623
31.63M
US$ 60.730M

Latest News From Medical Distribution Stocks


Patterson Companies Reports Fiscal 2024 Third Quarter Operating Results

Third quarter reported net sales increased 1.0 percent year-over-year to $1.62 billion. Internal sales increased 0.3 percent year-over-year, driven by dental consumables growth of 6.3 percent; excluding certain infection control products, internal sales of dental consumables increased 7.2 percent year-over-year. Delivered third quarter GAAP earnings of $0.52 per diluted share and adjusted earnings of $0.59 per diluted share. Returned $148.8 million to shareholders through... Read more


Bob Azelby to join Cardinal Health Board of Directors

DUBLIN, Ohio, Feb. 28, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors has elected Robert "Bob" Azelby as an independent director, effective March 1. Mr. Azelby joins the board with over 30 years of experience, including as a Chief Executive Officer and board member for large, matrixed organizations in the biopharmaceutical, oncology and other specialty industries. Mr. Azelby has previously served as President... Read more


Henry Schein Reports Fourth-Quarter and Full-Year 2023 Financial Results and Introduces 2024 Financial Guidance

Fourth quarter GAAP diluted EPS of $0.13. Solid fourth quarter financial results in line with the Company’s guidance provided on November 13, 2023. Fourth quarter non-GAAP diluted EPS of $0.66, reflects: $0.05 of acquisition-related expenses and adjustments, and an estimated $0.70 to $0.75 from the cybersecurity incident. Introduces guidance for full-year 2024 non-GAAP diluted EPS of $5.00 to $5.16, reflecting growth of 11% to 15% compared with 2023,... Read more


Owens & Minor Reports Fourth Quarter and Full Year 2023 Financial Results

Business Delivered Strong Operating Margin Improvement in Fourth Quarter Robust Full Year Operating Cash Flow Generation Enabled Significant Debt Reduction RICHMOND, Va. / Feb 20, 2024 / Business Wire / Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2023. Full Year 2023 Key Highlights: Consolidated revenue of $10.3 billion Delivered $741 million of operating cash flow Reduced total debt by... Read more


Henry Schein Presents Comprehensive Lineup of Solutions at the 2024 Chicago Dental Society Midwinter Meeting

Company's Holistic Approach to Elevating the Customer Experience on Display MELVILLE, N.Y. / Feb 19, 2024 / Business Wire / Henry Schein, Inc. (Nasdaq: HSIC) today announced it will present at the 2024 Chicago Dental Society Midwinter Meeting a comprehensive lineup of digital equipment, technology solutions, and business services designed to help dental practices operate more efficiently and effectively. The Midwinter Meeting, which is scheduled for February 22 to February... Read more


Great Elm Reports Fiscal 2024 Second Quarter Financial Results

WALTHAM, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Great Elm Group, Inc. (“we,” “our,” “GEG,” “Great Elm,” or “the Company”), (NASDAQ: GEG), an alternative asset manager, today announced financial results for its fiscal second quarter ended December 31, 2023. Fiscal Second Quarter 2024 and Other Recent Highlights On February 8, 2024, GECC raised $24 million of equity capital from a special purchase vehicle (“SPV”) that acquired GECC common stock... Read more


Prestige Consumer Healthcare Reports Third Quarter Fiscal 2024 Results

Revenue of $282.7 Million in Q3, Up 2.6% Versus Prior Year Diluted EPS of $1.06 in Q3, Up 2.2% Versus Prior Year Reduced Leverage Ratio to 2.9x at Quarter End Raising Full-Year Fiscal 2024 Earnings Outlook to Approximately $4.33 TARRYTOWN, N.Y., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended December 31, 2023. “We are pleased with our continued strong... Read more


McKesson Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance

IRVING, Texas / Feb 07, 2024 / Business Wire / McKesson Corporation (NYSE: MCK) has released its fiscal 2024 third quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, February 7th at 4:30 PM ET to review its financial results. The audio webcast of the... Read more


Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook

Revenue increased 12% to $57.4 billion GAAP1 operating earnings were $482 million; GAAP diluted EPS was $1.43 Non-GAAP operating earnings increased 20% to $562 million; non-GAAP diluted EPS increased 38% to $1.82 Fiscal 2024 non-GAAP EPS guidance raised to $7.20 to $7.35, from $6.75 to $7.002,3 Fiscal 2024 non-GAAP adjusted free cash flow guidance raised to ~$2.5 billion, from ~$2.0 billion Cardinal Health to acquire Specialty Networks, a technology-enabled mult... Read more


Cardinal Health to acquire Specialty Networks and its PPS Analytics platform, a technology enabled multi-specialty group purchasing and practice enhancement organization in urology, rheumatology and g

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates platform for Cardinal Health expansion across specialty therapeutic areas Transaction enhances capabilities of Cardinal Health Specialty and supports ongoing build of Navista™ Network DUBLIN, Ohio, Jan. 31, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today... Read more


Henry Schein One Partners with 42 North Dental to Drive Innovation with Cloud Technology and AI Diagnostics

Best-in-class one-platform approach sets standard of care throughout the patient journey for 100+ practices AMERICAN FORK, Utah / Jan 25, 2024 / Business Wire / Henry Schein One today announced that 42 North Dental is implementing the full range of the company’s cloud-based platform including Dentrix Ascend, Jarvis Analytics, TechCentral and its AI-enabled X-ray analysis tool, Detect AI, powered and manufactured by VideaHealth. 42 North Dental, a dental support o... Read more


McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference

McKesson Adds New Director; Announces Acquisition of Compile IRVING, Texas / Jan 09, 2024 / Business Wire / McKesson Corporation (NYSE: MCK) will present at the 42nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco today at 9:45 AM PT (12:45 PM ET). Executive leadership will provide a company overview followed by a fireside chat. The audio webcast will be available live at McKesson’s Investor Relations website at investor.... Read more


Henry Schein to Present at J.P. Morgan’s Healthcare Investor Conference

MELVILLE, N.Y. / Jan 03, 2024 / Business Wire / Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at J.P. Morgan’s Healthcare Investor Conference on Wednesday, January 10, 2024, at 10:30 a.m. PST / 1:30 p.m. EST, at The Westin St. Francis Hotel in San Francisco. Henry Schein’s presentations can be heard via live webcast by visiting... Read more


Henry Schein Enters Extremity Segment of Orthopedic Market

Agrees to Acquire a Majority Interest in TriMed, Forms Strategic Relationship With Extremity Medical LLC Creates Platform to Establish Strategic Presence In The Fast-Growing Upper- And Lower-Extremities Specialties Segment of the Orthopedic Market MELVILLE, N.Y. / Dec 20, 2023 / Business Wire / Henry Schein, Inc. (NASDAQ: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced plans to enter the upper-... Read more


Henry Schein Appoints Carole T. Faig as New Independent Director

MELVILLE, N.Y. / Dec 18, 2023 / Business Wire / Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that its Board of Directors has appointed Carole T. Faig as an independent director to serve until the 2024 Annual Meeting of Stockholders in May, when she is expected to stand for re-election to the Board by a vote of the Company’s stockholders. Ms. Faig brings to Henry... Read more


Owens & Minor Unveils Long-Term Strategy at Investor Day Today

Outlines new five-year strategic plan intended to unlock expanded profitability and growth profiles of the business, targeting 20% compounded earnings growth between 2024 to 2028 Investments and strong cash generation expectations are anticipated to support multi-faceted growth and a value-enhancing capital allocation program RICHMOND, Va. / Dec 06, 2023 / Business Wire / Owens & Minor, Inc. (NYSE-OMI) (the “Company”), a global healthcare solutions company that... Read more


Henry Schein: Zahn Dental Exclusively Distributes Myerson’s New Trusana™ 3D Premium Denture System

MELVILLE, N.Y. / Dec 04, 2023 / Business Wire / Zahn Dental, the dental laboratory business of Henry Schein, Inc. (Nasdaq: HSIC), announces its exclusive distribution of Myerson’s newly launched Trusana™ Premium Denture System. The system is comprised of the Trusana Premium 3D Tooth Resin, Trusana Premium 3D Denture Base Resin, and Trusana Bond Denture Adhesive. The three products work together to create a premium denture with optimal physical properties and esthetics... Read more


Patterson Companies Reports Fiscal 2024 Second Quarter Operating Results

Second quarter reported net sales increased 1.6 percent year-over-year to $1.65 billion. Internal sales increased 1.0 percent year-over-year, driven by dental consumables growth of 2.9 percent; excluding certain infection control products, internal sales of dental consumables increased 4.7 percent year-over-year. Delivered second quarter GAAP earnings of $0.42 per diluted share and adjusted earnings of $0.50 per diluted share. Returned $85.9 million to shareholders through... Read more


Henry Schein to Present at Nasdaq’s 49th Investor Conference

MELVILLE, N.Y. / Nov 28, 2023 / Business Wire / Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at Nasdaq’s 49th Investor Conference on Wednesday, December 6, 2023, at 10:00 a.m. GMT at The May Fair Hotel in London. Henry Schein’s presentations can be heard via live webcast by visiting https://investor.henryschein.com/webcasts. Replays... Read more


Patterson Dental Selects Pearl as New Integrated AI Provider

Patterson Dental brings Pearl’s industry leading dental AI toolset to Eaglesoft practice management software with a new integration and distribution partnership LOS ANGELES / Nov 20, 2023 / Business Wire / Pearl, the global leader in dental AI solutions, today announced a partnership with Patterson Dental, a subsidiary of Patterson Companies (Nasdaq: PDCO), to distribute Pearl’s Second Opinion® and Practice Intelligence® software solutions as well as to integrate... Read more


Henry Schein Reports Third-Quarter 2023 Financial Results and Updates Full-Year Guidance

GAAP diluted EPS of $1.05 and non-GAAP diluted EPS of $1.32, reflecting stable net total sales growth of 3.1% 2023 non-GAAP diluted EPS guidance of $4.43 to $4.71 updated to reflect: a narrowing of previous guidance to $5.18 to $5.26 from $5.18 to $5.35 due to softening macroeconomic conditions, and an estimated $0.55 to $0.75 business interruption impact from the recent cybersecurity incident, which excludes any future insurance claim recovery MELVILLE, N.Y.... Read more


Cardinal Health launches SmartGown™ EDGE Breathable Surgical Gown with ASSIST™ Instrument Pockets

SmartGown™ EDGE is the first pocketed surgical gown designed to help maintain instrument sterility and accessibility. DUBLIN, Ohio, Nov. 9, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its SmartGown™ EDGE Breathable Surgical Gown with ASSIST™ Instrument Pockets, created to provide surgical teams safe and convenient instrument access in the operating room. Exclusively available from Cardinal Health, the gown is designed to... Read more


Great Elm Reports Fiscal 2024 First Quarter Financial Results

WALTHAM, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Great Elm Group, Inc. (“we,” “our,” “GEG,” “Great Elm,” or “the Company”), (NASDAQ: GEG), an alternative asset manager, today announced financial results for its fiscal first quarter ended September 30, 2023. Fiscal First Quarter 2024 and Other Recent Highlights Fee paying assets under management totaled $451.4 million as of September 30, 2023, up 1% from June 30, 2023, and up approximately 5% ye... Read more


Henry Schein to Present at Upcoming Investor Conferences in November 2023

MELVILLE, N.Y. / Nov 07, 2023 / Business Wire / Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences: Stifel’s Healthcare Conference in New York on November 15, 2023, at 11:30 a.m. Eastern time. Piper Sandler Conference in New York on November 28, 2023, at 9:30 a.m. Eastern time. Evercore ISI HealthCONx... Read more


Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook

Revenue increased 10% to $54.8 billion GAAP1 operating loss was $14 million and GAAP diluted EPS was $0.02, driven by a Medical segment goodwill impairment Non-GAAP operating earnings increased 35% to $571 million, driven by significant increases in both Pharmaceutical segment profit and Medical segment profit; non-GAAP diluted EPS increased 44% to $1.73 Pharmaceutical segment profit grew 18% to $507 million and the Medical segment delivered $71 million in segment... Read more


Owens & Minor Reports Third Quarter 2023 Financial Results

Top Line Expansion Led by Healthy Demand in Patient Direct and Medical Distribution Operating Cash Flow Generation Supported $188 million in Total Debt Reduction RICHMOND, Va. / Nov 03, 2023 / Business Wire / Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2023. Third Quarter Key Highlights: Consolidated revenue of $2.59 billion Net loss per common share of $(0.08) and adjusted net income per common... Read more


Prestige Consumer Healthcare Reports Second Quarter Fiscal 2024 Results

Revenue of $286.3 Million in Q2, Ahead of Outlook Diluted EPS of $1.07 in Q2, Up Over 5% Versus Prior Year Reduced Leverage Ratio to 3.0x at Quarter End Reaffirming Full-Year Fiscal 2024 Revenue, Earnings, and Cash Flow Outlook TARRYTOWN, N.Y., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2023. “Our second quarter results build on... Read more


McKesson Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance

IRVING, Texas / Nov 01, 2023 / Business Wire / McKesson Corporation (NYSE: MCK) has released its fiscal 2024 second quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, November 1st at 4:30 PM ET to review its financial results. The audio webcast of the... Read more


Henry Schein Completes Acquisition of a Majority Interest in Shield Healthcare

MELVILLE, N.Y. / Oct 17, 2023 / Business Wire / Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced it has completed the acquisition of Shield Healthcare, Inc., a leading supplier of homecare medical products delivered directly to patients in their homes. Henry Schein announced the agreement to acquire Shield Healthcare on August 3, 2023. Headquartered in Valencia, Calif.,... Read more


Cardinal Health Launches Kangaroo OMNI™ Enteral Feeding Pump

The next generation in enteral feeding, Kangaroo OMNI™ delivers nutrition and hydration from hospital to home. DUBLIN, Ohio, Sept. 28, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its Kangaroo OMNI™ Enteral Feeding Pump, designed to help provide enteral feeding patients with more options to meet their personalized needs throughout their enteral feeding journey.Kangaroo OMNI™ is the first and only attitude independent enteral... Read more


Great Elm Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results

WALTHAM, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Great Elm Group, Inc. (“we,” “our,” “GEG,” “Great Elm,” or “the Company”), (NASDAQ: GEG), an alternative asset manager, today announced financial results for its fiscal fourth quarter and year ended June 30, 2023. Fiscal Fourth Quarter 2023 Highlights GEG collected incentive fees from Great Elm Capital Corp. (“GECC") for the first time in the Company’s history, totaling $1.0 million for the fourth... Read more


Henry Schein to Present at Goldman Sachs Global Sustainability Forum

MELVILLE, N.Y. / Sep 14, 2023 / Business Wire / Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at Goldman Sachs Global Sustainability Forum in New York on September 27, 2023, at 12:15 p.m. Eastern time. Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on... Read more


Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference

TARRYTOWN, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 7, 2023 at 3:00 p.m. ET.  All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by clicking here. For those unable to participate during the live... Read more


Henry Schein to Present at Investor Conferences in September 2023

MELVILLE, N.Y. / Sep 05, 2023 / Business Wire / Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences: Morgan Stanley 21st Annual Global Healthcare Conference in New York on September 11, 2023, at 10:00 a.m. Eastern time. Baird 2023 Global Healthcare Conference in New York on September 12, 2023, at 10:15... Read more


Cardinal Health Launches Next Generation Medical Device to Improve Neonatal Feeding

The NTrainer™ System 2.0 is the only FDA Class II biofeedback device designed to help newborns and infants born prematurely develop their non-nutritive sucking skills needed for independent oral feeding.  DUBLIN, Ohio, Aug. 30, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the launch of its next generation NTrainer™ System 2.0, a medical device designed to help premature and newborn infants develop the oral coordination skills important... Read more


Patterson Reports Fiscal 2024 First Quarter Operating Results

First quarter reported net sales increased 3.5 percent year-over-year to $1.6 billion, and internal sales increased 2.8 percent. Drove adjusted operating margin1 expansion for business overall and across both Dental and Animal Health segments. Delivered first quarter GAAP earnings of $0.32 per diluted share and adjusted earnings of $0.40 per diluted share, a 25 percent increase over the prior year period. Returned $54.9 million to shareholders through dividends and share... Read more


Genpact Extends Relationship to Transform McKesson's Finance Operations for Enhanced Service and Competitive Growth

Companies co-innovate with leading-edge technologies, advanced analytics, and improved process design to drive strategic business value with McKesson's digital finance operating model optimization  IRVING, Texas and NEW YORK, Aug. 16, 2023 /PRNewswire/ -- McKesson (NYSE: MCK), a diversified healthcare services leader, and Genpact (NYSE: G), a global professional services firm focused on delivering outcomes that transform businesses, today announced that... Read more


Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2023 at High End of Investor Day Guidance

Fourth quarter revenue increased 13% to $53.5 billion Fourth quarter GAAP1 operating earnings were $137 million and GAAP diluted loss per share was $0.25 Fourth quarter non-GAAP operating earnings increased 24% to $560 million and non-GAAP diluted EPS increased 48% to $1.55 Fourth quarter Pharmaceutical segment profit increased 12% to $504 million and Medical segment profit increased to $82 million Generated both operating cash flow and non-GAAP adjusted free cash... Read more


Henry Schein Launches New Equipment Repair Subscription Program

Henry Schein Thrive Service Plus Offers Dental Practitioners Comprehensive Expert Service for Large Equipment MELVILLE, N.Y. / Aug 09, 2023 / Business Wire / Henry Schein, Inc. (Nasdaq: HSIC) today announced the launch of its new equipment repair subscription offering – Henry Schein Thrive Service Plus, delivered by ServiceFirst – the newest addition to the exclusive portfolio of benefits and value offered as part of the Henry Schein Thrive Rewards program. This... Read more


Henry Schein Reports Solid Second-Quarter 2023 Financial Results and Affirms Full-year Guidance

Achieved internal sales growth of 3.3% in local currencies, excluding sales of PPE products and COVID-19 test kits, driven by strength in the North American dental businesses Second-quarter financial results with GAAP diluted EPS of $1.06, and non-GAAP diluted EPS of $1.31, reflecting solid core business growth offset by continued lower contributions from PPE products and COVID-19 test kit sales Affirms 2023 non-GAAP diluted EPS guidance of $5.18 to $5.35 MELVILLE,... Read more


Owens & Minor Reports Second Quarter 2023 Financial Results

Top-line Growth Driven by Strong Performance in Patient Direct Operating Model Realignment Program Remains on Track Operating Cash Flow of $313 Million, Inclusive of $115 Million in Receivables Sales RICHMOND, Va. / Aug 04, 2023 / Business Wire / Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2023. Second Quarter Key Highlights: Consolidated revenue of $2.56 billion Net loss per common share of $(0.37)... Read more


Henry Schein to Acquire a Majority Interest in Shield Healthcare, a Leading Supplier of Homecare Medical Products to Patients in the Home; Expands Henry Schein Medical’s Continuum-of-Care Delivery M

MELVILLE, N.Y. / Aug 03, 2023 / Business Wire / Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it has signed an agreement to acquire a majority ownership position in Shield Healthcare, Inc., a leading supplier of homecare medical products delivered directly to patients in their homes. The addition of Shield Healthcare will advance Henry Schein Medical’s co... Read more


Prestige Consumer Healthcare Reports First Quarter Fiscal 2024 Results

Revenue of $279.3 Million in Q1, up 0.8% versus Prior Year and up 1.8% excluding Foreign Currency Reduced Leverage Ratio to 3.2x at Quarter End and Completed $25 Million Share Repurchase Program Reaffirming Full-Year Fiscal 2024 Revenue, Earnings, and Cash Flow Outlook TARRYTOWN, N.Y., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2023. “We are pleased with our... Read more


McKesson Reports Fiscal 2024 First Quarter Results

IRVING, Texas / Aug 02, 2023 / Business Wire / McKesson Corporation (NYSE: MCK) has released its fiscal 2024 first quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, August 2nd at 4:30 PM ET to review its financial results. The audio webcast of the conference... Read more


Henry Schein Medical and Medpod Join Forces to Launch Medpac

Compact, Lightweight, and Portable Telediagnostic Solution Designed to Help Enhance Remote Patient Care MELVILLE, N.Y. / Jul 31, 2023 / Business Wire / Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), and Medpod Inc. today announced the launch of Medpac – a lightweight, portable telediagnostic solution that allows health care providers to offer comprehensive professional care regardless of location, helping to bridge the gap between... Read more


Henry Schein Enhances Liquidity Position With New $750 Million Credit Facility

Amends Existing $1 Billion Credit Facility, Bringing Total Liquidity to $1.8 Billion MELVILLE, N.Y. / Jul 13, 2023 / Business Wire / Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical professionals, today announced that it has closed on a new $750 million credit facility with a maturity date of July 2026. Henry Schein also amended its existing $1 billion revolving credit facility, including extending... Read more


Patterson Reports Fiscal 2023 Fourth Quarter and Year End Operating Results

Fourth quarter reported net sales increased 5.0 percent year-over-year to $1.7 billion, and internal sales increased 5.7 percent. Drove adjusted operating margin expansion during the fourth quarter and fiscal 2023 for business overall and across both Dental and Animal Health segments. Returned $156.8 million to shareholders in fiscal 2023 through dividends and share repurchases. Achieved fourth quarter GAAP earnings of $0.77 per diluted share and adjusted earnings1... Read more


Cardinal Health to build at-Home Solutions distribution center in South Carolina

New facility is the largest at-Home Solutions has built to date, set to accommodate continued business and home healthcare industry growth DUBLIN, Ohio, June 15, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today its plans to build a new distribution center in the Greenville, South Carolina, area, to support its at-Home Solutions business, a market-leading home healthcare medical supplies provider serving people with chronic and serious health conditions... Read more


Patterson Elects Meenu Agarwal to Board of Directors

ST. PAUL, Minn. / Jun 15, 2023 / Business Wire / Patterson Companies (Nasdaq: PDCO) today announced that Meenu Agarwal has been elected to the Patterson Companies Board of Directors, effective June 13, 2023. Ms. Agarwal currently serves as Group Senior Vice President, Customer Experience and Success of Workday, Inc., a leading provider of enterprise cloud applications for finance and human resources. Ms. Agarwal will serve on the Board’s Audit and Finance Committee. “As... Read more


Cardinal Health Investor Day to Highlight Long-Term Value Creation

Narrowing fiscal year 2023 non-GAAP diluted EPS guidance to $5.65 to $5.80, from $5.60 to $5.80 (13% growth at the mid-point)1 Providing preliminary fiscal year 2024 non-GAAP diluted EPS guidance of $6.45 to $6.70 (15% growth at the mid-points) Providing long-term financial targets reflecting 12% to 14% growth of non-GAAP diluted EPS (3-year CAGR)2 Raising long-term financial target for Pharmaceutical segment profit to 4% to 6% growth, from "low-single digit to mid-single... Read more

COPYRIGHT ©2023 HEALTH STOCKS HUB